Tuberculosis Trial, Recruiting NCT06347939 Sponsor: Region Skane Condition: Tuberculosis
Back to Tuberculosis

Tuberculosis Trial, Recruiting

NCT06347939
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have enlarged lymph nodes in the chest area (greater than 1 cm in size)
  • People for whom a clinical assessment and tissue sampling of these lymph nodes is already planned as part of their standard care
  • People who are 18 years of age or older
  • People who agree to take part in the study

Who may not be able to join:

  • People whose blood pressure or circulation is unstable at the time of the procedure
  • People who have had a heart attack within the six weeks before joining the study
  • People who have a life-threatening irregular heartbeat
  • People who are experiencing breathing failure or dangerously low blood oxygen levels, even with oxygen support
  • People who have a severe blockage of their windpipe (confirm with trial site)
  • People who have a high risk of bleeding
  • People who do not wish to take part in the study
  • People who do not speak Swedish and would need an interpreter during the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Region Skane
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 April 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Number of mediastinal cryobiopsies needed per patient to lead to a definite diagnosis.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov